In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation

OBJECTIVE: Our objective was to evaluate the trend of antithyroglobulin antibodies (TgAb) during follow-up of patients with differentiated thyroid cancer (DTC) treated without RAI, as well as their role in the risk of recurrence. SUBJECTS AND METHODS: This was a prospective, descriptive study. A tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zavala, Luis Felipe, Barra, María Inés, Olmos, Roberto, Tuttle, Michael, González, Hernán, Droppelmann, Nicolás, Mosso, Lorena, Domínguez, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522203/
https://www.ncbi.nlm.nih.gov/pubmed/31038590
http://dx.doi.org/10.20945/2359-3997000000123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522203/
https://www.ncbi.nlm.nih.gov/pubmed/31038590
http://dx.doi.org/10.20945/2359-3997000000123

Ejemplares similares